Clinical Trial Update: A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating intermittent fludarabine for psoriatic arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis
• Psoriatic Arthritis

Drugs mentioned

• Fludarabine (Fludarabine)

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Arthritis, Psoriatic, Psoriasis | Phase 2 | Status: COMPLETED